| # | Drug | Count |
|---|---|---|
| 0 | LORLATINIB | 47 |
| 1 | ATORVASTATIN CALCIUM | 42 |
| 2 | ASPIRIN | 40 |
| 3 | ASPIRIN 325 MG | 40 |
| 4 | ASPIRIN 81 MG | 40 |
| 5 | EZETIMIBE | 33 |
| 6 | METFORMIN | 32 |
| 7 | METFORMIN ER 500 MG | 32 |
| 8 | METFORMIN ER 750 MG | 32 |
| 9 | ROSUVASTATIN | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFLUOPERAZINE HYDROCHLORIDE | 2 | 0.0159 |
| 1 | SULFACETAMIDE SODIUM, SULFUR | 1 | 0.0087 |
| 2 | LORLATINIB | 47 | 0.0063 |
| 3 | BEMPEDOIC ACID AND EZETIMIBE | 3 | 0.0042 |
| 4 | BEXAROTENE | 5 | 0.0038 |
| 5 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 6 | CARBIDOPA TABLETS | 6 | 0.0020 |
| 7 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 8 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, AND MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | 1 | 0.0020 |
| 9 | CALCIUM SULFATE ANHYDROUS | 1 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 42 | 0.0016 |
| 1 | Leptin Analog [EPC] | 2 | 0.0016 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 10 | 0.0013 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 5 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 3 | 0.0009 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0006 |
| 7 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 27 | 0.0005 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |